Introducing a new RNA-seq platform for intracellular multimodal profiling that could transform cancer research and ...
Spatial-biology tools are collecting more comprehensive data, and companies that want to model cells in silico are hoovering ...
BioSkryb Genomics and Tecan Group, today introduced a high-throughput single-cell workflow, combining BioSkryb's 384-well format of the ResolveOME ™ Whole Genome and Transcriptome Single-Cell Core Kit ...
BioSkryb Genomics and Tecan report that they have introduced a high-throughput single-cell workflow, combining BioSkryb’s 384-well format of the ResolveOME™ whole genome and transcriptome single-cell ...
11d
Should Launch of Atera Spatial Biology Platform Require Action From 10x Genomics (TXG) Investors?
In April 2026, 10x Genomics launched Atera, an in situ spatial biology platform unveiled at AACR that offers whole-transcriptome, single-cell–sensitive spatial analysis across fresh-frozen and FFPE ...
27d
QIAGEN to Showcase New Sample to Insight Solutions for Complex Oncology Applications at AACR 2026
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it will showcase its oncology workflow applications at the American Association for Cancer Research (AACR) Annual Meeting 2026 ...
Combines BioSkyrb’s new ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit 384-well assay with Uno Single Cell Dispenser™ provided by Tecan in a single workflow Enables scalable, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results